16:0 Lyso PC
Manufacturer: Sigma Aldrich
CAS Number: 17364-16-8
Synonym(S): 1-hexadecanoyl-sn-glycero-3-phosphocholine; PC(16:0/0:0)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 855675P-25-MG | In Stock | ₹ 17,027.73 |
| 200 MG | 855675P-200-MG | In Stock | ₹ 21,942.28 |
| 500 MG | 855675P-500-MG | In Stock | ₹ 33,893.08 |
| 1 G | 855675P-1-G | In Stock | ₹ 59,429.25 |
855675P - 25 MG
In Stock
Quantity
1
Base Price: ₹ 17,027.73
GST (18%): ₹ 3,064.991
Total Price: ₹ 20,092.721
description
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine
Assay
>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
form
powder
packaging
pkg of 1 × 1 g (855675P-1g)pkg of 1 × 200 mg (855675P-200mg)pkg of 1 × 25 mg (855675P-25mg)pkg of 1 × 500 mg (855675P-500mg)
manufacturer/tradename
Avanti Polar Lipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCC)=O
InChI
1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1
InChI key
ASWBNKHCZGQVJV-HSZRJFAPSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Avanti Polar Lipids 16:0 Lyso PC | 17364-16-8 | MFCD00036904 | 200mg | -- | ₹ 20,278.65 | ||
Sigma Aldrich Fine Chemicals Biosciences 1-Palmitoyl-sn-glycero-3-phosphocholine synthetic, >=99% | 17364-16-8 | MFCD00036904 | 25MG | -- | ₹ 13,410.52 | ||
16:0 Lyso PC | -- | ₹ 15,502.50 - ₹ 19,855.13 | ||
1-Palmitoyl-sn-glycero-3-phosphocholine | -- | ₹ 12,416.28 - ₹ 55,911.13 | ||
1-Palmitoyl-sn-glycero-3-phosphocholine | -- | ₹ 4,806.00 - ₹ 79,477.00 | ||
17364-16-8 | 1-Palmitoyl-sn-glycero-3-phosphocholine | -- | ₹ 3,649.00 - ₹ 96,120.00 |
Related Products
Description
- Application: Microbubble-Mediated Drug Delivery: The role of 16:0 Lyso PC in the development of microbubble technologies for drug delivery systems emphasizes its potential in pharmaceutical formulations, enhancing the efficiency of targeted therapy applications, particularly in cancer treatment (Aron et al., 2019).Photodynamic Therapy for Glioma: Research involving 16:0 Lyso PC in the context of biohybrid systems for light-activatable treatments showcases its application in medical therapies, particularly for treating challenging conditions like glioma through photodynamic therapy, underlining its potential in enhancing clinical outcomes (Inglut et al., 2019).
- Packaging: 20 mL Clear Glass Screw Cap Vial (855675P-1g)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable